Table 2.
Baseline characteristics of participants
| Variable | Treatment (N=38) Mean (SD) | Control (N=36) Mean (SD) |
|---|---|---|
| Age (years) | 54.8 (8.8) | 54.0 (8.4) |
| Race (%) | ||
| White | 63 % | 69 % |
| Black | 29 % | 25 % |
| Hispanic | 8% | 6% |
| Weight (lbs) | 229.1 (64.4) | 226.9 (48.7) |
| Diabetes (years) | 10.5 (8.2) | 10.0 (6.5) |
| Mood outcomes | ||
| Depression | 27.7 (9.3) | 28.9 (9.5) |
| Trait anxiety | 51.6 (9.8) | 50.4 (9.2) |
| State anxiety | 45.8 (12.8) | 47.9 (11.9) |
| Anger expression | 40.6 (13.2) | 34.7 (13.9) |
| Trait anger | 19.8 (4.8) | 18.6 (5.7) |
| State anger | 18.7(6.5) | 18.1 (5.2) |
| Glycemic control | ||
| Glucose (mg/dl) | 165.3 (71.1) | 168.8 (74.9) |
| HBA1c (%) | 7.8 (1.8) | 7.9 (2.0) |
| Quality of life outcomes | ||
| Life satisfaction | ||
| Quality of life | 15.0 (5.2) | 15.5 (5.0) |
| Functional status | ||
| Mental health | 36.6 (10.0) | 37.2 (10.9) |
| Physical health | 38.0 (10.5) | 41.4 (9.4) |
There were no statistically significant differences between treatment and control groups for those randomized (38 vs. 36) and those who participated (34 vs. 36).